Literature DB >> 6989852

Demonstration of a primary (? genetic) defect in insulin receptors in fibroblasts from a patient with the syndrome of insulin resistance and acanthosis nigricans type A.

C R Kahn, J M Podskalny.   

Abstract

We have studied insulin binding to cultured skin fibroblasts from a patient with the Type A syndrome of insulin resistance and acanthosis nigricans. Insulin binding was decreased aobut 50% at low insulin concentrations. This was due to a decrease in receptor affinity and in increase in the rate of dissociation of insulin from the receptor. In addition, there was a loss of negative cooperativity, as measured by the ability of unlabeled insulin to accelerate dissociation. This defect in the receptor was stable for up to 16 passages of the cells. By contrast, binding of epidermal growth factor did not differ from control. These data suggest that the Type A syndrome of insulin resistance is due to a primary, and possibly genetic, defect in the insulin receptor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989852     DOI: 10.1210/jcem-50-6-1139

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Lipoatrophic diabetes.

Authors:  H Dörfler; G Rauh; R Bassermann
Journal:  Clin Investig       Date:  1993-04

2.  Definition and classification of diabetes.

Authors:  Z Laron
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

3.  Digenic Variants in the FGF21 Signaling Pathway Associated with Severe Insulin Resistance and Pseudoacromegaly.

Authors:  Stephen I Stone; Daniel J Wegner; Jennifer A Wambach; F Sessions Cole; Fumihiko Urano; David M Ornitz
Journal:  J Endocr Soc       Date:  2020-09-22

4.  Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance.

Authors:  T Kadowaki; H Kadowaki; M M Rechler; M Serrano-Rios; J Roth; P Gorden; S I Taylor
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance.

Authors:  E J Schoenle; P D Zenobi; T Torresani; E A Werder; M Zachmann; E R Froesch
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

6.  Insulin receptor degradation is accelerated in cultured lymphocytes from patients with genetic syndromes of extreme insulin resistance.

Authors:  A McElduff; J A Hedo; S I Taylor; J Roth; P Gorden
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

7.  Hyperinsulinism and insulin resistance in polycystic ovarian syndrome: a verification using oral glucose, I.V. Glucose and tolbutamide.

Authors:  G Cotrozzi; M Matteini; P Relli; T Lazzari
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun

8.  Pancreatic A and B cell hyperfunction in the Mendenhall syndrome.

Authors:  M Serrano Ríos; S de la Viña; M E Carbó; R E Nash; R Barrio; L G Heding
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

9.  Abnormal carbohydrate metabolism in a canine model for muscular dystrophy.

Authors:  Andressa R Amaral; Márcio A Brunetto; Marina P Brólio; Daniela S Cima; Maria A Miglino; João Paulo F Santos; Carlos E Ambrósio
Journal:  J Nutr Sci       Date:  2017-11-23

Review 10.  Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes.

Authors:  Amélie Bonnefond; Robert K Semple
Journal:  Diabetologia       Date:  2022-05-27       Impact factor: 10.460

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.